Myeloperoxidase: A new player in autoimmunity

Anna Strzepa1, Kirkwood A Pritchard2, Bonnie N Dittel3

  • 1Blood Research Institute, BloodCenter of Wisconsin, Milwaukee, WI, United States; Department of Medical Biology, Faculty of Health Sciences, Jagiellonian University Medical College, ul. Kopernika 7, 31-034 Krakow, Poland.

Cellular Immunology
|May 18, 2017
PubMed

Insights

Myeloperoxidase (MPO) is a neutrophil enzyme that can both fight infection and promote autoimmune diseases like multiple sclerosis and rheumatoid arthritis. Research suggests MPO plays a pathogenic role in autoimmune inflammation.

Area of Science:

  • Biochemistry
  • Immunology
  • Pathology

Background:

  • Myeloperoxidase (MPO) is a neutrophil enzyme crucial for pathogen killing via reactive oxidants.
  • While vital in infection, MPO and its byproducts are implicated in sterile inflammation and tissue damage.
  • Elevated MPO is observed in autoimmune diseases such as multiple sclerosis (MS) and rheumatoid arthritis (RA).

Purpose of the Study:

  • To investigate the dual role of MPO in health and autoimmune disease.
  • To elucidate the mechanisms by which MPO contributes to autoimmune pathogenesis.

Main Methods:

  • Utilized mouse models to demonstrate the pathogenic role of MPO.
  • Analyzed MPO activity and levels in autoimmune disease contexts.

Main Results:

  • Demonstrated a pathogenic role for MPO in driving autoimmune inflammation in experimental models.
  • Identified potential mechanisms including modulation of adaptive immunity and vascular permeability.

Conclusions:

  • MPO exhibits a complex role, acting as both a defense enzyme and a driver of autoimmune pathology.
  • Understanding MPO's mechanisms is critical for developing targeted therapies for autoimmune diseases like MS and RA.